Press Releases and Announcements

Welcome to our press releases and announcements area. On this page we have the latest announcements and through our archive you can find announcements form previous years.

Agreement to Exchange Dandrit Biotech A/S Shares with DKTI A/S Shares

Monday, November 12, 2012 - 16:55 — Shareholders holding more than 80% of Dandrit Biotech A/S's nominal share capital have agreed to exchange their shares in Dandrit Biotech A/S shares in DKTI A/S

Download full announcement (pdf)

DANDRIT invited at Jefferies 2012 Global Healthcare Conference in London taking place on 14-15 November

Monday, September 24, 2012 - 12:20 — DanDrit today announced that its CEO, Eric Leire, will be presenting at the Jefferies 2012 Global Healthcare Conference in London taking place on 14-15 November at the Waldorf Hilton.

Download full announcement (pdf)

DANDRIT to present at the 8th World Stem Cell Summit in West Palm Beach, Florida on December 5th 2012

Friday, August 24, 2012 - 14:00 — CEO Dr. Leire to discuss “Translational Studies in Cancer "

Download full announcement (pdf)

DANDRIT to present at the SMi's Inaugural Cancer Vaccines Conference, London, 19-20th September 2012

Monday, August 6, 2012 - 11:53 — CEO Dr. Leire to discuss "Overcoming challenges in cancer vaccine clinical development".

Download full announcement (pdf)

DANDRIT to present at Life Science Xchange 2012 European Summit in London on 21 June

Friday, May 25, 2012 - 14:08 — CEO Dr. Leire to discuss "The Virtual Model: New Rule for Emerging Biotech Companies"

Download full announcement (pdf)

European Patent Granted

Tuesday, May 8, 2012 - 14:00 — DANDRIT has been granted a European patent on one of its proprietary methods for generating dendritic cells.

Download full announcement (pdf)

DANDRIT to present at the Cancer Vaccines,3rd Annual Summit, in Boston, June 26-28 2012

Wednesday, May 2, 2012 - 10:00 — CEO Dr. Leire to discuss "Current Challenges in Designing and Conducting Phase II Oncology Clinical Trials"

Download full announcement (pdf)

Agreement regarding the conditions for the merger with DKTI A/S

Friday, April 27, 2012 - 17:57 — DanDrit Biotech A/S has reached an agreement with DKTI A/S regarding the valuation of DanDrit Biotech A/S. The parties have agreed on a valuation of USD 40 million.

Download full announcement (pdf)

Conclusion of merger agreement with DKTI

Thursday, December 22, 2011 - 07:00 — Dandrit has signed a merger agreement with DKTI A/S and Dandrit's majority shareholder, Biotech Invest ApS. The merger will be carried out In accordance with the Companies Act Chapter 15 and with DKTI as the continuing company.

Download full announcement (pdf)